Search - tctmd.com

Displaying 881 - 900 of 1097

Sort: Relevancy | Date

Presentation TCT 2015

Is Hemodynamic Collapse Due to Increased Afterload After MV Replacement in Severe MR With Reduced LVEF a Real Phenomenon?

Presenter: Michael J. Mack, Francesco Maisano, Patrick M. McCarthy

October 12, 2015

Presentation TCT 2015

For Years Weve Been Hearing Surgical MV Repair Is Always Preferable to Replacement So, Why Transcatheter MV Replacement?!

Presenter: Michael J. Mack, Francesco Maisano, John G. Webb

October 12, 2015

Presentation TCT 2015

Transcatheter Annuloplasty and Mitral Valve Replacement: Emerging Therapeutic Options

Presenter: Blase A. Carabello, Howard C. Herrmann

October 12, 2015

News Conference News TCT 2015

Experts Debate Mitral Valve Repair, Replacement for Intermediate-Risk Patients

October 12, 2015

Presentation TCT 2015

Debate: Repair vs Replacement for Secondary MR: Replacement Always!

Presenter: Michael J. Mack, Patrick M. McCarthy

October 11, 2015

Presentation TCT 2015

Debate: Repair vs Replacement for Secondary MR: Repair Always!

Presenter: Michael J. Mack, Patrick M. McCarthy, Khalil Fattouch

October 11, 2015

Presentation TCT 2015

Residual and Recurrent MR After MV Repair and Replacement: What Is the Data (for Primary vs Secondary MR)?

Presenter: Michael J. Mack, Patrick M. McCarthy, Allan Schwartz

October 11, 2015

Presentation TCT 2015

Acute and Late Results After Surgical Repair and Replacement of Degenerative MR

Presenter: Michael J. Mack, Patrick M. McCarthy, James S. Gammie

October 11, 2015

News Industry News

Valtech's CE Mark-Approved Cardioband® for Transcatheter Mitral Valve Repair to Be Highlighted at the 2015 Transcatheter Cardiovascular Therapeutics Annual Meeting

October 11, 2015

News Conference News TCT 2015

Cardioband Shows Benefits for Secondary Mitral Regurgitation

October 11, 2015

News Industry News

Boston Scientific Announces Additional Investment And Right To Acquire MValve Technologies

October 08, 2015

News Industry News

MValve Technologies Implants First Human Catheter Based Mitral Valve Replacement System

October 05, 2015

News Daily News

In the Early Days of TAVR, No Mortality Penalty for Patients Treated Outside of Trial Centers

October 01, 2015

News Daily News

En los Albores de la TAVR, No Hubo Más Mortalidad en Pacientes tratados en Centros No Participantes en Ensayos

October 01, 2015

News Industry News

Valtech's Cardioband® Receives CE Mark Approval for Mitral Valve Repair

September 14, 2015

News Industry News

Mitralign Receives FDA Approval for Percutaneous Tricuspid Repair Early Feasibility Study

August 31, 2015

News Daily News

La FA, Preexistente o de Nueva Aparición, se asoció a Peores Resultados en la TAVR

Yael L. Maxwell

August 30, 2015

News Daily News

A-fib, Whether Preexisting or New-Onset, Tied to Poor Outcomes in TAVR

Yael L. Maxwell

August 30, 2015

News Industry News

Edwards Lifesciences Corporation Completes Acquisition Of CardiAQ

August 27, 2015

News Daily News

新型经导管二尖瓣在小型系列研究中取得了治疗功能性二尖瓣反流的积极结果

August 25, 2015

Advertisement

Is Hemodynamic Collapse Due to Increased Afterload After MV Replacement in Severe MR With Reduced LVEF a Real Phenomenon?

For Years Weve Been Hearing Surgical MV Repair Is Always Preferable to Replacement So, Why Transcatheter MV Replacement?!

Transcatheter Annuloplasty and Mitral Valve Replacement: Emerging Therapeutic Options

Experts Debate Mitral Valve Repair, Replacement for Intermediate-Risk Patients

Debate: Repair vs Replacement for Secondary MR: Replacement Always!

Debate: Repair vs Replacement for Secondary MR: Repair Always!

Residual and Recurrent MR After MV Repair and Replacement: What Is the Data (for Primary vs Secondary MR)?

Acute and Late Results After Surgical Repair and Replacement of Degenerative MR

Valtech's CE Mark-Approved Cardioband® for Transcatheter Mitral Valve Repair to Be Highlighted at the 2015 Transcatheter Cardiovascular Therapeutics Annual Meeting

Cardioband Shows Benefits for Secondary Mitral Regurgitation

Boston Scientific Announces Additional Investment And Right To Acquire MValve Technologies

MValve Technologies Implants First Human Catheter Based Mitral Valve Replacement System

In the Early Days of TAVR, No Mortality Penalty for Patients Treated Outside of Trial Centers

En los Albores de la TAVR, No Hubo Más Mortalidad en Pacientes tratados en Centros No Participantes en Ensayos

Valtech's Cardioband® Receives CE Mark Approval for Mitral Valve Repair

Mitralign Receives FDA Approval for Percutaneous Tricuspid Repair Early Feasibility Study

La FA, Preexistente o de Nueva Aparición, se asoció a Peores Resultados en la TAVR

A-fib, Whether Preexisting or New-Onset, Tied to Poor Outcomes in TAVR

Edwards Lifesciences Corporation Completes Acquisition Of CardiAQ

新型经导管二尖瓣在小型系列研究中取得了治疗功能性二尖瓣反流的积极结果

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content